Microsimulation comparing three mt-sDNA rounds versus one colonoscopy over 10 years incorporated real-world adherence, test ...

Targeted maintenance therapy with gilteritinib (Xospata; Astellas) following allogeneic hematopoietic stem cell ...

In this episode of Managed Care Cast, Ella Hohmann speaks with Douglas Marks, MD, breast medical oncologist and associate ...

JoAnn Manson, MD, shares findings from the VIVID trial on vitamin D, the timing of use, and its potential to reduce long ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...

Manufacturer-sponsored biologic coupons have decreased since 2018, with rising per-claim values, impacting patient costs and ...

Ectopic germinal centers (GCs) were found to be a prognostic factor for poor outcomes for patients with thymoma-associated ...

Across tumor types, 1-year NGS uptake rose substantially from 2018 to 2022, reaching 74.5% in aNSCLC and 78.1% in mCRC, but ...

A new systematic review and meta-analysis appearing in the Journal of Sport and Health Science suggests that combining strength and aerobic exercise may offer greater improvements ...

Reclassifying vaccines as shared clinical decision-making creates an additional financial risk. If ACIP no longer ...

With obesity costing $1.4 trillion annually, Shawn Davis, MD, argues the return on treatment investment is clear if we build systems to measure it. One of the most pressing financial debates in ...